Africa-Press – Nigeria. The Federal Government of Nigeria, through the National Agency for the Control of AIDS, NACA, says it has secured a major breakthrough in HIV prevention after a landmark price reduction of the revolutionary drug, lenacapavir.
NACA made this announcement at the Clinton Global Initiative, CGI, 2025 Annual Meeting on the sidelines of the 80th United Nations General Assembly, UNGA, in New York.
According to NACA, under the new agreement, the cost of the twice-yearly HIV prevention injection has been slashed from $28,000 (N41.9 million) to just $40 (N60,000) per person per year.
This makes the medicine accessible to millions across Nigeria and more than 100 low- and middle-income countries.
Lenacapavir has been shown to be up to 100 percent effective in preventing new HIV infections.
Delivering Nigeria’s statement at the event, the Director-General of NACA, Dr Temitope Ilori, described the move as a turning point in the country’s fight against HIV.
She added that the agreement ensures innovation is paired with equity.
“Today marks a milestone in our fight against HIV in Nigeria and globally. Through this landmark access agreement, we are unlocking affordable access to lenacapavir – a transformational prevention option that offers longer protection, greater convenience, and renewed hope to millions at risk.
“This breakthrough does not remain a privilege for the few. It lays the foundation for broad, long-lasting impact for those who need it most,” Ilori said.
For More News And Analysis About Nigeria Follow Africa-Press
